Ecron Acunova has acquired aCROnordic, a full service CRO covering Denmark, Sweden, Finland and Norway, expanding Ecron’s clinical research presence in the region. Mr. Søren Strøh, founder and chief executive officer of aCROnordic, will continue in his role for the Nordic region.

Mr. D.A. Prasanna, founder and chairman of Ecron Acunova, said, “A recent change in the strategy of sponsors in the healthcare industry asks for more global presence of preferred provider CROs. The merger of EA and aCROnordic, both having decades of track record, an excellent reputation and deep local knowledge in their geographies, yields substantial synergy to both of us for serving our clients’ needs.”

“The merger has created great enthusiasm in aCROnordic. We see this as an opportunity to fulfill our dream of being the first Nordic development CRO in an international organization. The trust in this merger is the crowning consequence of our cooperation during the past 7 years. We have successfully delivered service on joint international projects with harmonized SOPs. As Nordic region’s leading CRO, we are happy to offer clients our well-known and personalized services on a larger geographic and therapeutic platform now,” said Mr. Strøh.